X4 Pharmaceuticals Inc (NASDAQ:XFOR) shares, rose in value on Wednesday, April 16, with the stock price down by -6.11% to the previous day’s close as strong demand from buyers drove the stock to $0.20.
Actively observing the price movement in the last trading, the stock closed the session at $0.21, falling within a range of $0.192 and $0.22. The value of beta (5-year monthly) was 0.581. Referring to stock’s 52-week performance, its high was $1.39, and the low was $0.19. On the whole, XFOR has fluctuated by -33.71% over the past month.
With the market capitalization of X4 Pharmaceuticals Inc currently standing at about $33.91 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-24.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 17.3M, with a low estimate of 1.5M and a high estimate of 29.49M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 7.03M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that XFOR’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of XFOR currently trading nearly -17.83% and -43.47% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 29.84, while the 7-day volatility ratio is showing 12.14% which for the 30-day chart, stands at 11.80%. Furthermore, X4 Pharmaceuticals Inc (XFOR)’s beta value is 0.70, and its average true range (ATR) is 0.03.
A comparison of X4 Pharmaceuticals Inc (XFOR) with its peers suggests the former has fared considerably weaker in the market. XFOR showed an intraday change of -6.11% in last session, and over the past year, it shrunk by -84.38%%.
Data on historical trading for X4 Pharmaceuticals Inc (NASDAQ:XFOR) indicates that the trading volumes over the past 10 days have averaged 1.84 and over the past 3 months, they’ve averaged 3.35 million. According to company’s latest data on outstanding shares, there are 170.95 million shares outstanding.
Nearly 33.77% of X4 Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 30.32% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.08 million shares as on 2025-03-31, resulting in a short ratio of 4.83. According to the data, the short interest in X4 Pharmaceuticals Inc (XFOR) stood at 471.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 9.48 million. The stock has fallen by -73.38% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the XFOR stock heading into the next quarter.
